ATLASATLAS fair value
ATLAS has no fair value for this stock today.
Kuros Biosciences (KURN.SW)
Kuros Biosciences stock price today, ATLAS forecast and fair value
Healthcare · Medical Devices · SIX Swiss Exchange · Switzerland
CHF 19.90▼ -5.24%
Prices as of Oct 27, 2026 · CHF
Chance of rising in 1 month
48%
that it ends higher than today in 21 sessions
0%coin flip 50%100%
This is just the summary. See everything on Kuros Biosciences in ATLAS
ATLAS's own quantitative analysis, all in one place.
- Simulation and expected rangeThousands of simulated scenarios: how far the price could rise or fall.
- Officers and shareholdersWho runs the company and which funds hold its shares.
- Customer and supplier mapWho it does business with, from its own filings.
- ATLAS builds your portfolioAnswer a short test and get portfolios that fit you.
- AlertsWe let you know when something changes in your stocks.
See everything included
- Valuation and financialsFair value step by step, quarterly accounts and upcoming events.
- NewsThe latest on the company, in one place.
- Crisis simulatorHow your portfolio would do in a crash like 2008.
- Practice risk-free$10,000 in virtual money to invest at real prices.
- Global screenerSearch US stocks and stocks from 47 countries with filters.
On Kuros Biosciences
- Simulation and expected rangeThousands of simulated scenarios: how far the price could rise or fall.
- Officers and shareholdersWho runs the company and which funds hold its shares.
- Customer and supplier mapWho it does business with, from its own filings.
- Valuation and financialsFair value step by step, quarterly accounts and upcoming events.
- NewsThe latest on the company, in one place.
And for you
- ATLAS builds your portfolioAnswer a short test and get portfolios that fit you.
- AlertsWe let you know when something changes in your stocks.
- Crisis simulatorHow your portfolio would do in a crash like 2008.
- Practice risk-free$10,000 in virtual money to invest at real prices.
- Global screenerSearch US stocks and stocks from 47 countries with filters.
Plans from €3.99 a month.
ATLAS's model gives Kuros Biosciences a 48% chance of finishing higher a month from now (21 trading sessions) than today: close to a coin flip.
In half of the simulated outcomes the price ends between CHF 17.82 and CHF 21.84; in 9 out of 10, between CHF 14.88 and CHF 26.15. Estimated annual volatility is 55%.
Price, last 12 months (weekly close)
Key numbers
- Market cap
- CHF 724M
- Market cap (USD)
- $873M
- P/E ratio
- 114.1
- 52-week high
- CHF 32.48
- 52-week low
- CHF 16.46
- Revenue (12 months)
- CHF 175M
- Gross margin
- 88.2%
- Operating margin
- 5.6%
- Net margin
- 5.1%
- Beta
- 0.76
What this means
ATLAS does not publish a fair value for KURN.SW right now, but it does show its odds of rising: close to a coin flip.
Over the last 52 weeks KURN.SW has traded between CHF 16.46 and CHF 32.48. Today it is 38.7% below that high and 21% above its low.
On the business: net margin is 5.1%; it trades at 114.1 times earnings.
Its beta is 0.76: it tends to move less than the market.
About the company
Kuros Biosciences AG engages in the commercialization and development of biologic technologies for musculoskeletal care in the United States of America, the European Union, and internationally. It operates through two segments, Medical Devices and Legacy Portfolio.
Want to see everything about Kuros Biosciences?
Get started →Plans from €3.99 a month.
Comparable companies
Other companies in the same line of business:
Frequently asked questions
What does Kuros Biosciences do?
Kuros Biosciences AG engages in the commercialization and development of biologic technologies for musculoskeletal care in the United States of America, the European Union, and internationally. It operates through two segments, Medical Devices and Legacy Portfolio.
What is the chance KURN.SW goes up next month?
48%: close to a coin flip. In half of the simulated outcomes, KURN.SW ends the month between CHF 17.82 and CHF 21.84.
How big is Kuros Biosciences and what is its P/E ratio?
Kuros Biosciences's market capitalization is CHF 724M. Its price-to-earnings (P/E) ratio is 114.1: you pay CHF 114.1 for each CHF 1.00 of yearly earnings.
How volatile is KURN.SW?
ATLAS estimates annual volatility at 55%. In a typical month, half of the outcomes end between CHF 17.82 and CHF 21.84.
Not investment advice. ATLAS estimates are produced by statistical models from public data; they can be wrong and past performance does not predict future results. Consider your own situation before investing. Disclaimer